Immune effector cell activation

"Immune effector cell activation" refers to the process by which various immune cells (typically T cells, B cells, NK cells, and others) are triggered via specific molecular signals—such as antigen recognition, cytokine stimulation, and co-stimulatory receptor engagement—to differentiate and perform their immune functions (e.g., cytotoxicity, cytokine production, recruitment of other immune cells)[1][4][5]. The process is central to both protective immunity (against infections and cancer) and to the pathogenesis of immunopathologies when misregulated.

Other names

Immune cell activationImmune effector function activationEffector lymphocyte activation

Enhancement or suppression of signaling pathways involved in effector cell activation Blockade of inhibitory receptors (e.g., checkpoint inhibitors) Activation through recombinant cytokines (e.g., IL-2) Engagement of co-stimulatory molecules (e.g., anti-CD28 agonists)